$PCRX
Pacira Biosciences Inc

2014 Q2 Form 10-Q Financial Statement

#000139681414000009 Filed on July 31, 2014

View on sec.gov

Income Statement

Concept 2014 Q2 2013 Q2
Revenue $47.17M $17.14M
YoY Change 175.16% 38.86%
Cost Of Revenue $19.95M $10.21M
YoY Change 95.36% 52.79%
Gross Profit $27.21M $6.927M
YoY Change 292.83% 22.41%
Gross Profit Margin 57.69% 40.41%
Selling, General & Admin $24.84M $14.08M
YoY Change 76.4% 35.22%
% of Gross Profit 91.28% 203.26%
Research & Development $5.216M $4.857M
YoY Change 7.39% 159.46%
% of Gross Profit 19.17% 70.12%
Depreciation & Amortization $2.300M $800.0K
YoY Change 187.5%
% of Gross Profit 8.45% 11.55%
Operating Expenses $50.01M $29.15M
YoY Change 71.54% 53.67%
Operating Profit -$2.842M -$12.01M
YoY Change -76.34% 81.26%
Interest Expense $2.079M $1.914M
YoY Change 8.62% 287.45%
% of Operating Profit
Other Income/Expense, Net -$2.195M -$2.021M
YoY Change 8.61% 21.02%
Pretax Income -$5.037M -$14.03M
YoY Change -64.1% 69.13%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$5.037M -$14.03M
YoY Change -64.1% 69.13%
Net Earnings / Revenue -10.68% -81.86%
Basic Earnings Per Share -$0.14 -$0.42
Diluted Earnings Per Share -$0.14 -$0.42
COMMON SHARES
Basic Shares Outstanding 35.46M shares 33.08M shares
Diluted Shares Outstanding 35.46M shares 33.08M shares

Balance Sheet

Concept 2014 Q2 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $163.9M $96.00M
YoY Change 70.73% 13.88%
Cash & Equivalents $108.2M $8.626M
Short-Term Investments $55.70M $87.30M
Other Short-Term Assets $5.300M $3.600M
YoY Change 47.22% 12.5%
Inventory $19.19M $14.22M
Prepaid Expenses
Receivables $20.55M $7.756M
Other Receivables $0.00 $0.00
Total Short-Term Assets $208.9M $121.5M
YoY Change 71.95% 21.4%
LONG-TERM ASSETS
Property, Plant & Equipment $53.51M $42.07M
YoY Change 27.22% 40.38%
Goodwill $12.52M $8.980M
YoY Change 39.42% 12.25%
Intangibles
YoY Change
Long-Term Investments $13.50M
YoY Change
Other Assets $3.103M $3.712M
YoY Change -16.41% 518.67%
Total Long-Term Assets $83.17M $56.94M
YoY Change 46.07% 33.11%
TOTAL ASSETS
Total Short-Term Assets $208.9M $121.5M
Total Long-Term Assets $83.17M $56.94M
Total Assets $292.1M $178.4M
YoY Change 63.69% 24.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.145M $1.712M
YoY Change 83.7% 328.0%
Accrued Expenses $23.04M $12.26M
YoY Change 87.89% 31.83%
Deferred Revenue
YoY Change
Short-Term Debt $101.0M $0.00
YoY Change
Long-Term Debt Due $900.0K $900.0K
YoY Change 0.0% -25.0%
Total Short-Term Liabilities $129.5M $15.84M
YoY Change 717.85% 3.93%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $96.89M
YoY Change -100.0% 274.1%
Other Long-Term Liabilities $4.384M $2.743M
YoY Change 59.83% -61.9%
Total Long-Term Liabilities $4.384M $99.64M
YoY Change -95.6% 201.01%
TOTAL LIABILITIES
Total Short-Term Liabilities $129.5M $15.84M
Total Long-Term Liabilities $4.384M $99.64M
Total Liabilities $144.1M $119.3M
YoY Change 20.81% 146.73%
SHAREHOLDERS EQUITY
Retained Earnings -$312.9M -$269.7M
YoY Change 16.04%
Common Stock $36.00K $33.00K
YoY Change 9.09%
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.000K
YoY Change
Treasury Stock Shares 0.000 shares 1.065K shares
Shareholders Equity $148.0M $59.14M
YoY Change
Total Liabilities & Shareholders Equity $292.1M $178.4M
YoY Change 63.69% 24.86%

Cashflow Statement

Concept 2014 Q2 2013 Q2
OPERATING ACTIVITIES
Net Income -$5.037M -$14.03M
YoY Change -64.1% 69.13%
Depreciation, Depletion And Amortization $2.300M $800.0K
YoY Change 187.5%
Cash From Operating Activities $8.220M -$13.31M
YoY Change -161.76% -34.17%
INVESTING ACTIVITIES
Capital Expenditures -$6.020M -$1.740M
YoY Change 245.98% -60.18%
Acquisitions
YoY Change
Other Investing Activities -$24.55M -$3.780M
YoY Change 549.47% -91.25%
Cash From Investing Activities -$30.58M -$5.520M
YoY Change 453.99% -88.39%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 111.8M 1.180M
YoY Change 9374.58% -98.16%
NET CHANGE
Cash From Operating Activities 8.220M -13.31M
Cash From Investing Activities -30.58M -5.520M
Cash From Financing Activities 111.8M 1.180M
Net Change In Cash 89.44M -17.65M
YoY Change -606.74% 369.41%
FREE CASH FLOW
Cash From Operating Activities $8.220M -$13.31M
Capital Expenditures -$6.020M -$1.740M
Free Cash Flow $14.24M -$11.57M
YoY Change -223.08% -27.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
3145000 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3069000 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14590000 USD
CY2014Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
20545000 USD
CY2014Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
23035000 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
17885000 USD
CY2014Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
15324000 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12576000 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
5000 USD
CY2014Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-31000 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
337639000 USD
CY2014Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
460907000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9512000 USD
CY2014Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5537000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4450000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9512000 USD
CY2013Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2225000 USD
CY2014Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 USD
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1890000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2069000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
600000 USD
CY2014Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
100000 USD
CY2013Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
500000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1000000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7223000 shares
CY2014Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7451000 shares
CY2013Q4 us-gaap Assets
Assets
169820000 USD
CY2014Q2 us-gaap Assets
Assets
292080000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
106751000 USD
CY2014Q2 us-gaap Assets Current
AssetsCurrent
208906000 USD
CY2014Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
69165000 USD
CY2013Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
59632000 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
108200000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12515000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10126000 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8626000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
535000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-525000 USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35836959 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33636442 shares
CY2014Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35836959 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33636442 shares
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
34000 USD
CY2014Q2 us-gaap Common Stock Value
CommonStockValue
36000 USD
CY2014Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5073000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14062000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-16550000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-37183000 USD
CY2013Q4 us-gaap Convertible Debt
ConvertibleDebt
120000000 USD
CY2014Q2 us-gaap Convertible Debt
ConvertibleDebt
120000000 USD
CY2013Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
98961000 USD
CY2014Q2 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
101031000 USD
CY2014Q2 us-gaap Cost Of Revenue
CostOfRevenue
19954000 USD
CY2013Q2 us-gaap Cost Of Revenue
CostOfRevenue
10214000 USD
us-gaap Cost Of Revenue
CostOfRevenue
21605000 USD
us-gaap Cost Of Revenue
CostOfRevenue
38081000 USD
CY2014Q2 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
3500000 shares
CY2014Q2 us-gaap Debt Instrument Convertible Threshold Consecutive Trading Days
DebtInstrumentConvertibleThresholdConsecutiveTradingDays
P30D
CY2014Q2 us-gaap Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger
DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
1.3
CY2014Q2 us-gaap Debt Instrument Convertible Threshold Trading Days
DebtInstrumentConvertibleThresholdTradingDays
20 D
CY2013Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
21039000 USD
CY2014Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
18969000 USD
CY2014Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1426000 USD
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1008000 USD
CY2014Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
10221000 USD
CY2013Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3212000 USD
CY2013Q2 us-gaap Depreciation
Depreciation
800000 USD
us-gaap Depreciation
Depreciation
1700000 USD
CY2014Q2 us-gaap Depreciation
Depreciation
2300000 USD
us-gaap Depreciation
Depreciation
4300000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2717000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4936000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.13
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.42
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.48
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.13
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.48
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2144000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
532000 USD
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.14
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.42
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
13843000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
14436000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
15000000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
15000000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
564000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1157000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
31000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
157000 USD
CY2014Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2013Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-3398000 USD
CY2014Q2 us-gaap Goodwill
Goodwill
12520000 USD
CY2013Q4 us-gaap Goodwill
Goodwill
10328000 USD
CY2012Q2 us-gaap Goodwill
Goodwill
8000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-37611000 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5037000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14031000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16514000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-442000 USD
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5226000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3260000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3403000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5955000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
7426000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-486000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3637000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
332000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1263000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
711000 USD
CY2014Q2 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
100000 USD
CY2013Q2 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
300000 USD
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
100000 USD
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
600000 USD
us-gaap Interest Expense
InterestExpense
3433000 USD
us-gaap Interest Expense
InterestExpense
4185000 USD
CY2013Q2 us-gaap Interest Expense
InterestExpense
1914000 USD
CY2014Q2 us-gaap Interest Expense
InterestExpense
2079000 USD
us-gaap Interest Paid
InterestPaid
2583000 USD
us-gaap Interest Paid
InterestPaid
846000 USD
CY2014Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
6355000 USD
CY2013Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
3946000 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
15557000 USD
CY2014Q2 us-gaap Inventory Net
InventoryNet
19194000 USD
CY2014Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
7369000 USD
CY2013Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
5290000 USD
CY2013Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
6321000 USD
CY2014Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
5470000 USD
CY2014Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
61000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
145000 USD
CY2013Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
72000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
103000 USD
CY2014Q2 us-gaap Liabilities
Liabilities
144111000 USD
CY2013Q4 us-gaap Liabilities
Liabilities
128571000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
169820000 USD
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
292080000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
121943000 USD
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
129506000 USD
CY2014Q2 us-gaap Long Term Debt
LongTermDebt
101031000 USD
CY2013Q4 us-gaap Long Term Debt
LongTermDebt
98961000 USD
CY2013Q4 us-gaap Long Term Investments
LongTermInvestments
0 USD
CY2014Q2 us-gaap Long Term Investments
LongTermInvestments
13474000 USD
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-1500000 USD
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
95685000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
87373000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
113758000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-21555000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-61774000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-27099000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
3482000 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-14031000 USD
us-gaap Net Income Loss
NetIncomeLoss
-37169000 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-5037000 USD
us-gaap Net Income Loss
NetIncomeLoss
-16514000 USD
CY2013Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2021000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4415000 USD
CY2014Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2195000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6955000 USD
us-gaap Operating Expenses
OperatingExpenses
95927000 USD
us-gaap Operating Expenses
OperatingExpenses
59384000 USD
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
29151000 USD
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
50007000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-12099000 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-12010000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-30656000 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2842000 USD
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
40453000 USD
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
5725000 USD
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
5578000 USD
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
5436000 USD
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
5297000 USD
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
15899000 USD
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
2518000 USD
CY2014Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3103000 USD
CY2014Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-36000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3402000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-14000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-36000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-31000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-36000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-14000 USD
CY2013Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-31000 USD
CY2014Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-36000 USD
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3190000 USD
CY2014Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4384000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-77000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-22000 USD
CY2013Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-18000 USD
CY2014Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-41000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
7191000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
13481000 USD
us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4672000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9831000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
87220000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
52992000 USD
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3139000 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2819000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
120000000 USD
CY2014Q2 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
110400000 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
30800000 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
56941000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2064000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3351000 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
60758000 USD
CY2014Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
68837000 USD
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
53513000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
48182000 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
0 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
27500000 USD
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4857000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10420000 USD
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5216000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10762000 USD
CY2013Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1633000 USD
CY2014Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
2168000 USD
CY2014Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-312943000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-296429000 USD
CY2014Q2 us-gaap Revenues
Revenues
47165000 USD
us-gaap Revenues
Revenues
28728000 USD
CY2013Q2 us-gaap Revenues
Revenues
17141000 USD
us-gaap Revenues
Revenues
83828000 USD
us-gaap Royalty Expense
RoyaltyExpense
256000 USD
CY2014Q2 us-gaap Royalty Expense
RoyaltyExpense
136000 USD
us-gaap Royalty Expense
RoyaltyExpense
247000 USD
CY2013Q2 us-gaap Royalty Expense
RoyaltyExpense
161000 USD
CY2013Q2 us-gaap Royalty Revenue
RoyaltyRevenue
620000 USD
us-gaap Royalty Revenue
RoyaltyRevenue
1129000 USD
us-gaap Royalty Revenue
RoyaltyRevenue
1478000 USD
CY2014Q2 us-gaap Royalty Revenue
RoyaltyRevenue
809000 USD
CY2013Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
16278000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
81776000 USD
CY2014Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
46034000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
27113000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
47426000 USD
CY2013Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
14080000 USD
CY2014Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
24837000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
27017000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
9512000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
4450000 USD
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
8129537 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1720012 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
6409525 shares
CY2014Q2 us-gaap Share Price
SharePrice
91.86
CY2014Q2 us-gaap Share Price
SharePrice
64.00
CY2013Q4 us-gaap Short Term Investments
ShortTermInvestments
59637000 USD
CY2014Q2 us-gaap Short Term Investments
ShortTermInvestments
55660000 USD
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
0 shares
CY2014Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1840000 shares
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3351000 USD
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
147969000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
41249000 USD
CY2013Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
0 shares
CY2014Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
0 shares
CY2014Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
35463000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
34587000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
32896000 shares
CY2013Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33083000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32896000 shares
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35463000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34587000 shares
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33083000 shares
pcrx Amortization Of Other Assets And Unfavorable Lease Obligation
AmortizationOfOtherAssetsAndUnfavorableLeaseObligation
216000 USD
pcrx Amortization Of Other Assets And Unfavorable Lease Obligation
AmortizationOfOtherAssetsAndUnfavorableLeaseObligation
243000 USD
pcrx Antidilutive Securities Excludedfrom Computationof Earnings Per Share Amount Treasury Stock Method
AntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareAmountTreasuryStockMethod
5200000 shares
CY2014Q2 pcrx Antidilutive Securities Excludedfrom Computationof Earnings Per Share Amount Treasury Stock Method
AntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareAmountTreasuryStockMethod
5300000 shares
pcrx Antidilutive Securities Excludedfrom Computationof Earnings Per Share Amount Treasury Stock Method
AntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareAmountTreasuryStockMethod
2400000 shares
CY2013Q2 pcrx Antidilutive Securities Excludedfrom Computationof Earnings Per Share Amount Treasury Stock Method
AntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareAmountTreasuryStockMethod
2800000 shares
CY2014Q2 pcrx Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
14000 USD
CY2013Q4 pcrx Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
13000 USD
CY2014Q2 pcrx Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
45000 USD
CY2013Q4 pcrx Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
8000 USD
CY2013Q2 pcrx Collaborative Licensing And Development Revenue
CollaborativeLicensingAndDevelopmentRevenue
243000 USD
CY2014Q2 pcrx Collaborative Licensing And Development Revenue
CollaborativeLicensingAndDevelopmentRevenue
322000 USD
pcrx Collaborative Licensing And Development Revenue
CollaborativeLicensingAndDevelopmentRevenue
574000 USD
pcrx Collaborative Licensing And Development Revenue
CollaborativeLicensingAndDevelopmentRevenue
486000 USD
CY2012Q2 pcrx Contingent Payment Obligation Established For Sale Of Product In Connection With Acquisition
ContingentPaymentObligationEstablishedForSaleOfProductInConnectionWithAcquisition
2000000 USD
CY2014Q2 pcrx Debt Instrument Convertible Conversion Premium Shares
DebtInstrumentConvertibleConversionPremiumShares
3500000 shares
CY2014Q2 pcrx Debt Instrument Convertible Conversion Value
DebtInstrumentConvertibleConversionValue
324000000 USD
CY2014Q2 pcrx Employee Stock Purchase Plan Espp Sharesin Espp
EmployeeStockPurchasePlanESPPSharesinESPP
500000 shares
pcrx Employee Stock Purchase Plan Numberof Shares Authorized
EmployeeStockPurchasePlanNumberofSharesAuthorized
500000 shares
pcrx Employee Stock Purchase Plan Numberof Shares Available For Purchase
EmployeeStockPurchasePlanNumberofSharesAvailableForPurchase
500000 shares
CY2014Q2 pcrx Employee Stock Purchase Planfairvalue
EmployeeStockPurchasePlanfairvalue
0.85
pcrx Equity Premium Convertible Debt
EquityPremiumConvertibleDebt
0 USD
pcrx Equity Premium Convertible Debt
EquityPremiumConvertibleDebt
24936000 USD
pcrx Goodwill Recordedfor Earn Out Payments
GoodwillRecordedforEarnOutPayments
2192000 USD
pcrx Increase Decrease In Royalty Interest Obligation
IncreaseDecreaseInRoyaltyInterestObligation
205000 USD
pcrx Increase Decrease In Royalty Interest Obligation
IncreaseDecreaseInRoyaltyInterestObligation
377000 USD
CY2013Q4 pcrx Long Term Debt Including Royalty Interest Obligation
LongTermDebtIncludingRoyaltyInterestObligation
100207000 USD
CY2014Q2 pcrx Long Term Debt Including Royalty Interest Obligation
LongTermDebtIncludingRoyaltyInterestObligation
101900000 USD
CY2013 pcrx Number Of Major Customers
NumberOfMajorCustomers
3 customer
pcrx Number Of Major Customers
NumberOfMajorCustomers
3 customer
CY2012Q2 pcrx Payment Obligation Arising Due To First Commercial Sale Of Product In Connection With Acquisition
PaymentObligationArisingDueToFirstCommercialSaleOfProductInConnectionWithAcquisition
10000000 USD
pcrx Payment Of Contingent Consideration
PaymentOfContingentConsideration
2192000 USD
pcrx Payment Of Contingent Consideration
PaymentOfContingentConsideration
682000 USD
pcrx Proceeds From Sale Of Unused Net Operating Losses
ProceedsFromSaleOfUnusedNetOperatingLosses
400000 USD
CY2013Q4 pcrx Royalty Interest Obligation
RoyaltyInterestObligation
1246000 USD
CY2014Q2 pcrx Royalty Interest Obligation
RoyaltyInterestObligation
869000 USD
CY2013Q4 pcrx Royalty Interest Obligation Current
RoyaltyInterestObligationCurrent
1020000 USD
CY2014Q2 pcrx Royalty Interest Obligation Current
RoyaltyInterestObligationCurrent
869000 USD
CY2013Q4 pcrx Royalty Interest Obligation Noncurrent
RoyaltyInterestObligationNoncurrent
226000 USD
CY2014Q2 pcrx Royalty Interest Obligation Noncurrent
RoyaltyInterestObligationNoncurrent
0 USD
pcrx Stock Issued During Period Proceeds Followon Public Offering Issues
StockIssuedDuringPeriodProceedsFollowonPublicOfferingIssues
110407000 USD
pcrx Stock Issued During Period Proceeds Followon Public Offering Issues
StockIssuedDuringPeriodProceedsFollowonPublicOfferingIssues
0 USD
pcrx Stock Issued During Period Value Follow On Public Offering Issues
StockIssuedDuringPeriodValueFollowOnPublicOfferingIssues
110407000 USD
CY2014Q2 pcrx Total Goodwill Recordedfor Earn Out Payments
TotalGoodwillRecordedforEarnOutPayments
4600000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Period End Date
DocumentPeriodEndDate
2014-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001396814
CY2014Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
35891951 shares
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
Pacira Pharmaceuticals, Inc.

Files In Submission

Name View Source Status
0001396814-14-000009-index-headers.html Edgar Link pending
0001396814-14-000009-index.html Edgar Link pending
0001396814-14-000009.txt Edgar Link pending
0001396814-14-000009-xbrl.zip Edgar Link pending
ex102image1.gif Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
pcrx-20140630.xml Edgar Link completed
pcrx-20140630.xsd Edgar Link pending
pcrx-20140630_cal.xml Edgar Link unprocessable
pcrx-20140630_def.xml Edgar Link unprocessable
pcrx-20140630_lab.xml Edgar Link unprocessable
pcrx-20140630_pre.xml Edgar Link unprocessable
pcrx-63014xex101.htm Edgar Link pending
pcrx-63014xex102.htm Edgar Link pending
pcrx-63014xex103.htm Edgar Link pending
pcrx-63014xex311.htm Edgar Link pending
pcrx-63014xex312.htm Edgar Link pending
pcrx-63014xex321.htm Edgar Link pending
pcrx-63014xex322.htm Edgar Link pending
pcrx-6302014x10xq.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending